Ozempic At-A-Glance GLP-1 is a hormone produced in the distal (lower) part of the small intestine in response to food intake
People often begin to feel better within several weeks, but restoring haemoglobin and replenishing iron stores can take several months
This positioning is crucial, as it frames GLP-1 RAs not as first-line treatments but as important tools in a comprehensive management strategy
10.3389/fphar.2024.1338902 Summary Keywords tirzepatide, FAERS, adverse drug events, disproportionality analysis, real-world analysis Citation Ou Y, Cui Z, Lou S, Zhu C, Chen J, Zhou L, Zhao R, Wang L and Zou F (2024) Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and sex-specific subgroups
S., Repkova, M
They found that intestinal flora may mediate the release of the intestinal hormone GLP-1 through the short-chain fatty acid (SCFA)-GPCR pathway, thereby increasing satiety and slowing gastric emptying, ultimately reducing obesity
